@genetic-counselor
Genetic Counselor
Forum Replies Created
-
Posts
-
This is the most important question for any parent to understand, because the value of newborn screening lies in one key fact: a baby can look perfectly healthy at birth and still have a condition that will cause serious harm within weeks if it goes unnoticed.
Conditions like congenital hypothyroidism (an underactive thyroid gland from birth) or phenylketonuria (a condition where the body cannot break down a specific protein building block called phenylalanine) do not show any symptoms in the first days of life. By the time symptoms do appear, such as feeding difficulties, unusual sleepiness, or slowed development, some damage may already have been done, and in certain conditions, this damage cannot be reversed.
Newborn screening changes this outcome entirely. If a condition is picked up early, treatment can often begin before any damage occurs. For example:
*A baby with congenital hypothyroidism can be started on a simple daily thyroid hormone replacement and go on to develop completely normally.
*A baby with certain metabolic disorders can be managed with a specific diet or supplement, avoiding the complications that would occur if the condition were missed.
*A baby with hearing loss detected early can begin intervention within the first months of life, which makes a significant difference to speech and language development.In short, newborn screening does not prevent these conditions from existing. What it does is give doctors and parents a head start, so the condition can be managed before it affects the baby’s health or development.
Newborn screening is recommended for every baby, without exception, and this is worth explaining clearly to parents. It is a common misunderstanding that only babies with a family history of a genetic condition need to be screened. In reality, the vast majority of babies found to have one of these conditions have no family history of it at all. The condition can occur even when both parents are healthy and have no known genetic disorders in the family.
That said, newborn screening becomes even more important in certain situations, and parents in these situations should discuss an expanded screening panel with their doctor:
*When there is a known genetic or metabolic condition in the family
*When one or both parents are known carriers of a genetic condition
*When the parents are blood relatives (a consanguineous marriage), which increases the chance of certain inherited conditions
*When a previous child in the family was diagnosed with a treatable genetic or metabolic condition
*When the pregnancy or delivery involved complications that raise the baby’s riskIn these situations, a clinical geneticist may recommend testing for a wider range of conditions than what is included in the standard newborn screening panel offered at most hospitals.
Newborn screening is usually done between 24 and 72 hours after birth. This specific timing matters more than most parents realize. If the blood sample is collected too early, before the baby has fed a few times, some conditions may not yet show up in the blood, leading to a false sense of reassurance. If it is delayed too long, the window for early treatment starts to narrow, which reduces the benefit of screening in the first place.
Here is what typically happens, step by step:
*A trained healthcare worker collects a few drops of blood from the baby’s heel onto a special filter paper card, which is designed to preserve the sample for laboratory testing.
*This card is sent to a laboratory, where it is tested for a panel of conditions, often between 6 and 50 depending on the hospital and the package chosen by the family.
*Separately, a hearing screening is done using a small earpiece connected to a computer, usually while the baby is resting. This does not require any needles or discomfort.
*Results for the blood-based tests usually take a few days to a couple of weeks, depending on the laboratory.If a result comes back as abnormal or borderline, it does not mean the baby definitely has the condition. Newborn screening is a screening test, not a diagnostic test. Its job is to flag babies who need a closer look. If a result is flagged, the doctor will order a confirmatory test, which is more detailed and specific, to either confirm or rule out the condition. Parents should understand that an abnormal screening result is a signal to investigate further, not a final diagnosis, and most flagged results, when followed up, turn out to be false alarms.
It is important for parents to have a realistic picture of what newborn screening can and cannot do.
What it does not do:
*It does not test for every genetic or medical condition that exists. The panel only includes conditions that are treatable, serious enough to justify testing, and detectable reliably through a blood or hearing test.
*A normal result does not guarantee that the baby has no genetic conditions at all. It only means the baby has tested negative for the specific conditions included in that screening panel.
*It is not always perfectly accurate. Like any test, it can occasionally produce a false positive (flagging a healthy baby) or, more rarely, a false negative (missing a condition that is actually present).What it does change, in very concrete terms:
*It allows treatment to begin in the first days or weeks of life, during the window when intervention makes the biggest difference.
*For conditions like congenital hypothyroidism, early treatment with a daily hormone tablet can allow a baby to grow and develop completely normally, whereas a delayed diagnosis could lead to permanent developmental delay.
*For certain metabolic disorders, early dietary changes can prevent complications that would otherwise be very difficult, or impossible, to reverse once symptoms appear.
*For hearing loss, early identification allows intervention to begin well before a delay in speech and language would normally be noticed, which significantly improves outcomes.In simple terms, newborn screening does not change whether a baby has a condition. What it changes is when the condition is found, and finding it early, before any symptoms appear, is often the single biggest factor in how well a baby goes on to do.
Yes, in many cases. Knowing the specific genetic cause of a condition can help doctors choose more targeted treatments, adjust dosing for certain medications, or refine a management plan that’s more precise than a general approach.
It can still be a useful step. Preconception carrier screening looks for common recessive conditions regardless of family history, since carriers usually have no symptoms and no way of knowing otherwise. It’s a proactive option some couples choose simply for peace of mind.
Yes. This is called preimplantation genetic testing (PGT), and it screens embryos created through IVF for specific genetic conditions or chromosomal abnormalities before they are transferred, often used by couples with a known hereditary condition in the family.
Newborn screening is a specific type of testing done shortly after birth to check for a set of treatable conditions, some of which are genetic or metabolic. It’s usually done through a small blood sample and is different from broader diagnostic genetic testing, which is used to investigate a specific concern.
Newborn screening is a set of tests done shortly after birth, usually with a small blood sample, to check for certain treatable conditions, some of which are genetic or metabolic. Early detection through newborn screening allows treatment to begin promptly, often before any symptoms appear, which can make a significant difference in the child’s outcome.
This depends on the family’s specific history, but it’s often considered earlier than standard screening guidelines if a close relative was diagnosed with cancer at a young age, or if multiple family members have had related cancers. A genetic counselor can recommend a personalized starting point.
Options vary by condition but can include more frequent or earlier screening, preventive medications, lifestyle adjustments, and in some cases, risk-reducing procedures. These are discussed in detail with your care team based on your specific gene change and personal risk factors.
Not automatically. If a specific gene change has been identified in the family, a negative result for that particular change is reassuring for you individually. But it doesn’t rule out risk for other relatives unless they are also tested.
A chromosome is a tightly packaged structure made of DNA, and genes are specific segments within that DNA that carry instructions for building and running the body. Think of a chromosome as a book and genes as individual chapters within it.
Yes, this can happen with recessive conditions, where a carrier parent shows no symptoms and passes the gene silently to the next generation, and it may only become apparent again if the other parent also happens to be a carrier.
Spinal muscular atrophy is an inherited neuromuscular disorder that leads to progressive loss of motor neurons in the spinal cord and lower brainstem. Motor neurons are the nerve cells responsible for transmitting signals from the spinal cord to skeletal muscles. When these neurons degenerate, the muscles they control receive fewer signals, resulting in progressive muscle weakness and wasting (atrophy).
In more than 95 percent of cases, spinal muscular atrophy is caused by a deletion or mutation in both copies of the SMN1 gene (survival motor neuron 1), located on chromosome 5. SMN1 is responsible for producing most of the functional survival motor neuron protein, which is essential for motor neuron health and survival.
Humans also carry a nearly identical backup gene called SMN2. SMN2 produces some functional survival motor neuron protein, but far less than SMN1, because most of its genetic transcript is spliced incorrectly. The number of SMN2 copies a person carries (which varies between individuals) partly determines how much functional protein is still produced when SMN1 is lost, and this is a major factor influencing disease severity.
Spinal muscular atrophy follows an autosomal recessive pattern of inheritance. This means a child is affected only when both copies of the SMN1 gene, one inherited from each parent, carry a deletion or mutation. Parents who each carry one altered copy are called carriers and are typically healthy, with no symptoms themselves.
